AzTrials
AzTrials

Multiple SclerosisSetebNCT05142111

Pilot Study on EEG and Behavioral Effects of Two Different Treatments on Sexual Life

A study testing Therapy in people with Multiple Sclerosis and Spinal Cord Injuries, run by IRCCS San Camillo, Venezia, Italy at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In this study patients with Multiple Sclerosis or Spinal Lesions will participate in two different types of treatments that aim to improve sexual and sentimental life. Behavioral (via questionnaires) and brain (via high-density electroencephalogram) effects associated with treatment will be studied. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Multiple Sclerosis, Spinal Cord Injuries
What is being tested?
Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteItaly
Study dates
1 Apr 2021to 31 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • medical diagnosis of MS or spinal injury.
  • ability to sign informed consent.

Who cannot join

  • other relevant previous neurological or psychiatric pathologies.

Trial locations and contacts

1 site in 1 country.

Italy1 site, 1 recruiting
  • IRCCS San Camillo

    Venice, 30126

    Giorgio Arcara, PhD, n.ricercaclinica@hsancamillo.it

    Recruiting

Other trials in Italy

About this study

In this study patients with Multiple Sclerosis or Spinal Lesions will participate in two different types of treatments that aim to improve sexual and sentimental life. Behavioral (via questionnaires) and brain (via high-density electroencephalogram) effects associated with treatment will be studied.

Read the detailed description

People with neurological diseases can experience sexual disorders that can affect their quality of life. There are cognitive treatments to improve these aspects, but their effectiveness is not clear. The aim of this study is to test the potential efficacy of two treatments (mindfulness and sezual therapy) in two neurological populations (patients with multiple sclerosis and patients with spinal injury). To verify the effects of the treatment, questionnaires and brain activity measurements, measured by electroencephalogram, will be used.

Being tested
Therapy
Keywords
sexuality
Medical subject headings
Multiple Sclerosis, Spinal Cord Injuries, Sexuality

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TherapyBehavioural

    Discussion with therapist

Study groups in NCT05142111
Study groupRoleWhat they receive
Sexual therapyExperimentalIn the sessions a series of questions will be proposed to the subject, who will be free to answer or not, being able to express questions in turn. The sessions will last about 45 minutes, and will be held once a week, for a total of 6 sessions.
Receives: Behavioral: Therapy
MindfulnessActive comparatorDuring the mindfulness treatment the subjects will be subjected to sessions in which they will be invited to relax, to become aware of the present moment, of their body, through exercises that involve breathing, attention, and visualization of the body. The sessions will last about 45 minutes, and will be held once a week, for a total of 6 sessions.
Receives: Behavioral: Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in quality of actual and perceived sexual health for females

    Assessed by means of a standardized questionnaire

    Female Sexual Dysfunction Questionnaire (Filocamo et al., 2014). 19 questions with 6 choices each. No maximum or minimum score defined. The experimenter evaluates the changes across sessions.

    This will be aggregated to other outcomes using factor analysis

    Measured: Before and after treatment (circa 6 weeks)

  2. Changes in quality of actual and perceived sexual health for males

    Assessed by means of a standardized questionnaire

    MSHQ- (The Male Sexual Health Questionnaire). Questionnaire on male sexual health (Ugolini, \& Pescatori, 2005). 25 questions with 5 or 6 choices each. No maximum or minimum score defined. The experimenter evaluates the changes across sessions.

    This will be aggregated to other outcomes using factor analysis

    Measured: Before and after treatment (circa 6 weeks)

  3. Changes in erectile function

    Assessed by means of a standardized questionnaire

    IIEF5- (International Index of Erectile Function). Questionnaire aimed at calculating the International Index of Erectile Function (Rosen et al., 1997). 5 questions with scores 1 to 5. Outcome range 5-25. Lower scores indicate poorer outcomes.

    This will be aggregated to other outcomes using factor analysis

    Measured: Before and after treatment (circa 6 weeks)

  4. Changes in intimacy and sexuality

    Assessed by means of a standardized questionnaire

    MSISQ-15 (Multiple Sclerosis Intimacy and Sexuality Questionnaire). Questionnaire on Intimacy and Sexuality in People with a Medullary Injury (Monti et al., 2020). 15 items with scores 1 to 5 each. Outcome range 15-75. Higher scores indicate poorer outcomes.

    This will be aggregated to other outcomes using factor analysis

    Measured: Before and after treatment (circa 6 weeks)

Secondary outcomes (5)
  1. Changes in brain spectral power after viewing neutral and erotic videos

    Changes in response of brain networks at rest and during viewing of emotional stimuli with sexual content. The recording will consist of 5 minutes of resting state (recording at rest). 8 total minutes of viewing of stimuli consisting of videos with an erotic and neutral emotional content. In particular, the subject will see two videos with an erotic content and two with an emotionally neutral content (the duration of each video is about 2 minutes). These stimuli will be selected from a standardized and validated visual battery for scientific studies presented in (Maffei \& Angrilli, 2019).

    The spectral power across brain regions will be assessed by parametric spectral decomposition

    -presence and modulation of large scale patterns of correlated activity, assessed by means of measures of statistical dependency (correlation, mutual information)

    Measured: Before and after treatment (circa 6 weeks)

  2. Changes in Mutual Information between brain regions after viewing neutral and erotic videos

    Changes in response of brain networks at rest and during viewing of emotional stimuli with sexual content. The recording will consist of 5 minutes of resting state (recording at rest). 8 total minutes of viewing of stimuli consisting of videos with an erotic and neutral emotional content. In particular, the subject will see two videos with an erotic content and two with an emotionally neutral content (the duration of each video is about 2 minutes). These stimuli will be selected from a standardized and validated visual battery for scientific studies presented in (Maffei \& Angrilli, 2019).

    The presence and modulation of large scale patterns of correlated activity, assessed by means of mutual information (minimal value zero, maximum value not univocally defined, depending on the data distribution), will be investigated.

    Measured: Before and after treatment (circa 6 weeks)

  3. Psychological Well-Being

    Assessed by means of a standardized questionnaire

    PWB (Psychological Well-Being Scale). Questionnaire aimed at defining the patient's psychological well-being profile through items that evaluate the dimensions of self-acceptance, autonomy, environmental control, life purpose, personal growth and positive relationships with others (Ruini et al., 2003). 42 items with scores 1-6 each. Outcome range 42-252. Higher values indicated better well-being.

    Questionnaire responses will be aggregated by factor analysis

    Measured: Before and after treatment (circa 6 weeks)

  4. Anxiety

    Assessed by means of a standardized questionnaire

    BAI (Beck Anxiety Inventory). Questionnaire consisting of 21 items that describe anxiety in its subjective, neurophysiological and autonomic aspects. (Sica \& Ghisi, 2007; Starosta \& Brenner, 2018). The BAI has also been found to be a tool with high sensitivity to anxiety levels in patients with multiple sclerosis (Watson et al., 2014). 21 items, with scores 1-4 each. Outcome range 21-84. Higher values indicate higher anxiety.

    Questionnaire responses will be aggregated by factor analysis

    Measured: Before and after treatment (circa 6 weeks)

  5. Changes in the assessment of the emotional response after viewing neutral and erotic videos

    Self-assessment questionnaires of the emotional content of stimuli, in particular the self-assessment manikin (SAM) will be used (Bradley MM, Lang PJ). With this questionnaire, through pictorial representations of "mannequins", the patient will be asked to evaluate his emotional reactions while watching the videos, in terms of the intensity of the emotions felt and the positive or negative values of the sensations experienced during the vision.

    9 mannequins for valence (score 1:sad, score 9: happy). 9 mannequins for arousal (increasing level 1 to 9).

    Measured: Before and after treatment (circa 6 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2021
  2. Study start1 Apr 2021
  3. Primary completion31 Mar 2025 (estimated)
  4. Study completion31 Mar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05142111
Sponsor's protocol ID
2020.12
Acronym
Seteb
Status last verified
Oct 2023
First submitted
25 Aug 2021
Last updated
4 Oct 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The investigators are trying to figure out compliance to EU GDPR, its interpretation in Italy, and the institutional requirements

Publications

  • Chandler BJ, Brown S. Sex and relationship dysfunction in neurological disability. J Neurol Neurosurg Psychiatry. 1998 Dec;65(6):877-80. doi: 10.1136/jnnp.65.6.877.

    PubMed 9854964
  • Maffei A, Angrilli A. E-MOVIE - Experimental MOVies for Induction of Emotions in neuroscience: An innovative film database with normative data and sex differences. PLoS One. 2019 Oct 3;14(10):e0223124. doi: 10.1371/journal.pone.0223124. eCollection 2019.

    PubMed 31581254
  • McCabe MP. Evaluation of a cognitive behavior therapy program for people with sexual dysfunction. J Sex Marital Ther. 2001 May-Jun;27(3):259-71. doi: 10.1080/009262301750257119.

    PubMed 11354931

Questions about this trial

What is this clinical trial studying?

A study testing Therapy in people with Multiple Sclerosis and Spinal Cord Injuries, run by IRCCS San Camillo, Venezia, Italy at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Giorgio Arcara, PhD (+390412207594, n.ricercaclinica@ospedalesancamillo.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in quality of actual and perceived sexual health for females (time frame: Before and after treatment (circa 6 weeks)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05142111, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in